Clinical trial
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile…
NCT00304356 · Daniel M. Musher MD, U.S. Fed · Completed
Key facts
| NCT number | NCT00304356 |
|---|---|
| Title | Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection |
| Official title | Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy |
| Lead sponsor | Daniel M. Musher MD, U.S. Fed |
| Collaborators | Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Clostridium Enterocolitis, Pseudomembranous Colitis |
| Intervention type | Drug |
| Interventions | Nitazoxanide |
| Enrollment | 22 |
| Start date | Jan 1, 2004 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Mar 17, 2006 |
| Last update posted | Dec 15, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: